Drugs Made In America Acquisition LLC 4
4 · Drugs Made In America Acquisition Corp. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Transactions
- Purchase
Ordinary shares
2025-02-18+30,000→ 4,188,780 total - Purchase
Rights to receive ordinary shares
2025-02-18+30,000→ 430,000 total→ Ordinary shares (30,000 underlying)
Footnotes (2)
- [F1]Reflects the 30,000 private units acquired by the reporting person, the Issuer's sponsor. Each private unit consists of one ordinary share and one right to receive one-eighth (1/8) of an ordinary share upon the consummation of an initial business combination. The private units were purchased at $10 per unit for an aggregate purchase price of $300,000.
- [F2]The rights convert automatically into ordinary shares at the completion of the Issuer's initial business combination.